Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cantarovich M et al. – The use of long–term anti–CD25 MAb therapy as a potential replacement for CNI– and rapamycin–based immunosuppression is feasible. It is crucial that rejection surveillance be intensified. A randomized, controlled trial is required to confirm the benefits and safety of this strategy.

Related Articles

Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09    Relevance Score: 94%

Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09    Relevance Score: 94%

Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 94%

Factors influencing liver transplant length of stay at two large-volume transplant centers
Liver Transplantation, 11/03/09    Relevance Score: 93%

Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 93%

Today in Transplantation...keeping you current

Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: Report of a case
Surgery Today, 12/18/09

Survival impact of lung transplantation for chronic obstructive pulmonary disease
European Respiratory Journal , 12/17/09

Effect of Liver Transplantation on Spleen Size, Collateral Veins, and Platelet Counts
World Journal of Surgery, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address